Dr. R.P. “Kris” Iyer
Director, Co-Founder, Chief Scientific Officer
Spring Bank Pharmaceuticals
R. P. Iyer, (Kris), Ph.D., FRSC is the co-founder and Chief Scientific Officer of Spring Bank Pharmaceuticals. He has more than 25 years’ experience in Biotechnology industry in drug discovery and development in diverse therapeutic areas including antivirals, inflammation and immune-oncology. Kris is a leading innovator in the fields of nucleic acid chemistry, bioorganic chemistry and pharmaceutical sciences with over 100 publications and 200 issued, as well as, filed US and international patents. Prior to Spring Bank, Kris was the co-founder and VP of Discovery of Origenix Technologies and also served as Associate Director of Antisense Discovery at Hybridon, Inc. He currently serves on the Board of Directors of Spring Bank Pharmaceuticals and is a member of the Scientific Advisory Board of Oligomerix, Inc., NY.